Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06305910
Title CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors OX2 Therapeutics
Indications
Therapies
Age Groups: child | adult
Covered Countries USA


No variant requirements are available.